Literature DB >> 30722101

Bidirectional association between tuberculosis and sarcoidosis.

Sheng-Huei Wang1, Chi-Hsiang Chung2,3, Tsai-Wang Huang4, Wen-Chiuan Tsai5, Chung-Kan Peng1, Kun-Lun Huang1,6, Wann-Cherng Perng1, Chih-Feng Chian1, Wu-Chien Chien2,7, Chih-Hao Shen1.   

Abstract

BACKGROUND AND
OBJECTIVE: Tuberculosis (TB) and sarcoidosis are both granulomatous diseases with potential interassociations. However, much uncertainty remains; thus, the present study aimed to clarify the association between these diseases.
METHODS: We established two cohorts in this retrospective longitudinal cohort study using data obtained from the Taiwan National Health Insurance Database from 2000 to 2015. One cohort, which comprised 31 221 patients with TB and 62 442 age-, sex- and index year-matched controls, was used to analyse the risk of sarcoidosis; the other cohort comprised 2442 patients with sarcoidosis and 9688 controls and was used to assess the risk of TB. A Cox proportional hazards model adjusted for potential confounders was used in each cohort.
RESULTS: Patients with TB showed an 8.09-fold higher risk of developing sarcoidosis than non-TB subjects (95% CI = 3.66-17.90), whereas patients with sarcoidosis showed a 1.85-fold higher risk of developing TB than non-sarcoidosis subjects (95% CI = 1.36-2.50). The TB subtype analysis revealed the highest risk of developing sarcoidosis in patients with extrapulmonary TB, and the highest risk of developing extrapulmonary TB was observed in patients with sarcoidosis compared with non-sarcoidosis subjects. Patients with TB showed a higher risk of developing sarcoidosis throughout the follow-up period, but patients with sarcoidosis only showed a higher risk of developing TB within the first year.
CONCLUSION: TB is a risk factor for developing sarcoidosis. The results of this bidirectional cohort study also highlight the clinical difficulty of diagnosing sarcoidosis and TB.
© 2019 Asian Pacific Society of Respirology.

Entities:  

Keywords:  bidirectional association; granulomatous diseases; risk factor; sarcoidosis; tuberculosis

Mesh:

Year:  2019        PMID: 30722101     DOI: 10.1111/resp.13482

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

1.  Risk factors of relapse in pulmonary sarcoidosis treated with corticosteroids.

Authors:  Yi Zheng; Hui Wang; Qingqing Xu; Xin Yan; Yi Zhuang; Hanyi Jiang; Fanqing Meng; Yonglong Xiao; Hourong Cai; Jinghong Dai
Journal:  Clin Rheumatol       Date:  2019-03-15       Impact factor: 2.980

2.  Serpiginoid choroiditis, tuberculosis, and sarcoidosis.

Authors:  De-Kuang Hwang
Journal:  Taiwan J Ophthalmol       Date:  2019-09-12

3.  Association of iron deficiency anemia with tuberculosis in Taiwan: A nationwide population-based study.

Authors:  Kuo-An Chu; Chun-Hsiang Hsu; Mei-Chen Lin; Yi-Hsin Chu; Yao-Min Hung; James Cheng-Chung Wei
Journal:  PLoS One       Date:  2019-08-30       Impact factor: 3.240

4.  Impact of pangolin bootleg market on the dynamics of COVID-19 model.

Authors:  Abd Ullah; Saeed Ahmad; Ghaus Ur Rahman; M M Alqarni; Emad E Mahmoud
Journal:  Results Phys       Date:  2021-02-19       Impact factor: 4.476

5.  DNA sequencing validation by PCR-RFLP for evaluating butyrophilin-like 2 rs2076530 polymorphism in Iranian patients with sarcoidosis.

Authors:  Alireza Javadi; Masoud Zarei; Mihan Pourabdollah; Makan Sadr; Arda Kiani; Atefeh Abedini; Masoud Shamaei
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-01-13       Impact factor: 1.803

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.